HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$31.35
Day range
$29.79 - $31.66
Year range
$29.16 - $53.27
Market cap
1.95B USD
Avg Volume
573.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.39M | -84.56% |
Operating expense | 16.33M | 14.80% |
Net income | -70.75M | -392.43% |
Net profit margin | -956.88 | -3,088.54% |
Earnings per share | -0.89 | -256.00% |
EBITDA | -80.17M | -326.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 488.74M | 30.37% |
Total assets | 978.04M | 69.87% |
Total liabilities | 142.42M | -21.22% |
Total equity | 835.62M | — |
Shares outstanding | 64.94M | — |
Price to book | 2.43 | — |
Return on assets | -20.06% | — |
Return on capital | -21.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -70.75M | -392.43% |
Cash from operations | -61.78M | -867.98% |
Cash from investing | 68.57M | 261.80% |
Cash from financing | 2.76M | 42.97% |
Net change in cash | 9.55M | -66.99% |
Free cash flow | -37.46M | -691.96% |
About
Founded
2015
Headquarters
Website
Employees
188
